Although our results do not establish the biological mechanism by which TIMP3 affects survival, TIMP3 is involved in a variety of steps affecting cancer progression, including the induction of apoptosis [35] and anti-angiogenesis [36] possibly by directly binding to VEGF receptor 2 or inhibiting ADAM-17 activity [37]. This evidence concerns the gene ADAM17 and cancer.